The canonical BMP signaling pathway is involved in human monocyte-derived dendritic cell maturation

Immunology and Cell Biology

Volumn 89, Issue 5, 2011, Pages 610-618

  Martínez, Víctor G ^a   Hernández López, Carmen ^a   Valencia, Jaris ^a   Hidalgo, Laura ^a   Entrena, Ana ^a   Zapata, Agustín G ^a   Vicente, Angeles ^a   Sacedón, Rosa ^a   Varas, Alberto ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

bone morphogenetic proteins; dendritic cells; dorsomorphin; Id proteins; Runx proteins

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CD83 ANTIGEN; DORSOMORPHIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INTERLEUKIN 8; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DNA BINDING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

BONE MORPHOGENETIC PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CORE BINDING FACTOR ALPHA SUBUNITS; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNIZATION; LEUKOCYTES, MONONUCLEAR; MONOCYTES; PHENOTYPE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 79960021197     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.135     Document Type: Article

References (64)

1. Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35-51.
2. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005; 16: 251-263. (Pubitemid 40910315)
3. Sieber C, Kopf J, Hiepen C, Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 2009; 20: 343-355.
4. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci STKE 2002; 2002: PE40.
5. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-899.
6. Reddi AH. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev 2005; 16: 249-250. (Pubitemid 40910314)
7. Chen D, Zhao M, Harris SE, Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 2004; 9: 349-358. (Pubitemid 38925465)
8. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-1594. (Pubitemid 26268864)
9. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB et al. BMP-6 inhibits human bone marrow B lymphopoiesis-upregulation of Id1 and Id3. Exp Hematol 2006; 34: 72-81. (Pubitemid 43069603)
10. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol 2005; 6: 9.
11. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, Sundan A. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001; 97: 516-522. (Pubitemid 32060339)
12. Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004; 23: 3024-3032. (Pubitemid 38648193)
13. Cejalvo T, Sacedon R, Hernandez-Lopez C, Diez B, Gutierrez-Frias C, Valencia J et al. Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development. Immunology 2007; 121: 94-104. (Pubitemid 46537667)
14. Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. The developmentally regulated expression of twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med 2002; 196: 163-171. (Pubitemid 34787506)
15. Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, Vicente A et al. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol 2002; 169: 5496-5504. (Pubitemid 35291647)
16. Varas A, Sacedon R, Hidalgo L, Martinez VG, Valencia J, Cejalvo T et al. Interplay between BMP4 and IL-7 in human intrathymic precursor cells. Cell Cycle 2009; 8: 4119-4126.
17. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur J Immunol 2007; 37: 2937-2948. (Pubitemid 47578312)
18. Varas A, Martinez VG, Hernandez-Lopez C, Hidalgo L, Entrena A, Valencia J et al. Role of BMP signalling in peripheral CD4 T cell proliferation. Inmunoloǵa 2009; 28: 125-130.
19. Lu L, Ma J, Wang X, Wang J, Zhang F, Yu J et al. Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol 2010; 40: 142-152.
20. Takai S, Tokuda H, Matsushima-Nishiwaki R, Saio M, Takami T, Kozawa O. TGF-beta superfamily enhances the antigen-induced IFN-gamma production by effector/memory CD8T cells. Int J Mol Med 2010; 25: 105-111.
21. Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 1992; 89: 11740-11744. (Pubitemid 23004719)
22. Perron JC, Dodd J. ActRIIA and BMPRII type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis. PLoS One 2009; 4: e8198.
23. Hong JH, Lee GT, Lee JH, Kwon SJ, Park SH, Kim SJ et al. Effect of bone morphogenetic protein-6 on macrophages. Immunology 2009; 128: e442-e450.
24. Kwon SJ, Lee GT, Lee JH, Kim WJ, Kim IY. Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 2009; 128: e758-e765.
25. Pluchino S, Zanotti L, Brambilla E, Rovere-Querini P, Capobianco A, Alfaro-Cervello C et al. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One 2009; 4: e5959.
26. Billings PC, Fiori JL, Bentwood JL, O'Connell MP, Jiao X, Nussbaum B et al. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res 2008; 23: 305-313. (Pubitemid 351304661)
27. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281-292. (Pubitemid 37487702)
28. Hong CC, Yu PB. Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev 2009; 20: 409-418.
29. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008; 4: 33-41. (Pubitemid 350273653)
30. Hon H, Rucker III EB, Hennighausen L, Jacob J. bcl-xL is critical for dendritic cell survival in vivo. J Immunol 2004; 173: 4425-4432. (Pubitemid 39280672)
31. Nopora A, Brocker T. Bcl-2 controls dendritic cell longevity in vivo. J Immunol 2002; 169: 3006-3014. (Pubitemid 35013143)
32. Hernandez-Lopez C, Valencia J, Hidalgo L, Martinez VG, Zapata AG, Sacedon R et al. CXCL12/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2/Bax ratio. Immunol Lett 2008; 120: 72-78.
33. Breton G, Yassine-Diab B, Cohn L, Boulassel MR, Routy JP, Sekaly RP et al. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8T cells from HIV-1-infected individuals. J Clin Immunol 2009; 29: 637-645.
34. Karakhanova S, Meisel S, Ring S, Mahnke K, Enk AH. ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur J Immunol 2010; 40: 254-266.
35. Cohen Jr MM. Perspectives on RUNX genes: an update. Am J Med Genet A 2009; 149A: 2629-2646.
36. Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003; 13: 43-47. (Pubitemid 36143926)
37. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004; 23: 969-979. (Pubitemid 38418763)
38. Detmer K, Walker AN. Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haematopoietic progenitors. Cytokine 2002; 17: 36-42.
39. Wilke A, Traub F, Kienapfel H, Griss P. Cell differentiation under the influence of rh-BMP-2. Biochem Biophys Res Commun 2001; 284: 1093-1097. (Pubitemid 32917950)
40. Fuchs O, Simakova O, Klener P, Cmejlova J, Zivny J, Zavadil J et al. Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4. Blood Cells Mol Dis 2002; 28: 221-233. (Pubitemid 34743756)
41. Morikawa Y, Zehir A, Maska E, Deng C, Schneider MD, Mishina Y et al. BMP signaling regulates sympathetic nervous system development through Smad4-dependent and -independent pathways. Development 2009; 136: 3575-3584.
42. Solmesky LJ, Abekasis M, Bulvik S, Weil M. Bone morphogenetic protein signaling is involved in human mesenchymal stem cell survival in serum-free medium. Stem Cells Dev 2009; 18: 1283-1292.
43. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006; 98: 209-217.
44. Izumi M, Fujio Y, Kunisada K, Negoro S, Tone E, Funamoto M et al. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem 2001; 276: 31133-31141.
45. Yabe T, Samuels I, Schwartz JP. Bone morphogenetic proteins BMP-6 and BMP-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons. J Neurosci Res 2002; 68: 161-168. (Pubitemid 34275009)
46. Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 2008; 68: 198-205. (Pubitemid 351380121)
47. Barneda-Zahonero B, Minano-Molina A, Badiola N, Fado R, Xifro X, Saura CA et al. Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway. Mol Biol Cell 2009; 20: 5051-5063.
48. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S et al. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 2005; 23: 411-419. (Pubitemid 41571106)
49. Yang X, Fullerton DA, Su X, Ao L, Cleveland Jr JC, Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol 2009; 53: 491-500.
50. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S et al. Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 2006; 281: 27229-27241. (Pubitemid 44401752)
51. Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 2009; 45: 367-376.
52. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004; 200: 400-406. (Pubitemid 39006932)
53. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 2003; 85-A(Suppl 3): 59-66. (Pubitemid 36951118)
54. Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM et al. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1473-L1479. (Pubitemid 47077364)
55. Nimmo R, Woollard A. Worming out the biology of Runx. Dev Biol 2008; 313: 492-500.
56. Puig-Kroger A, Dominguez-Soto A, Martinez-Munoz L, Serrano-Gomez D, Lopez-Bravo M, Sierra-Filardi E et al. RUNX3 negatively regulates CD36 expression in myeloid cell lines. J Immunol 2006; 177: 2107-2114. (Pubitemid 44200968)
57. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci USA 2002; 99: 8048-8053. (Pubitemid 34651003)
58. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4: 380-386. (Pubitemid 36432322)
59. Robson NC, Phillips DJ, McAlpine T, Shin A, Svobodova S, Toy T et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 2008; 111: 2733-2743.
60. Scutera S, Riboldi E, Daniele R, Elia AR, Fraone T, Castagnoli C et al. Production and function of activin A in human dendritic cells. Eur Cytokine Netw 2008; 19: 60-68.
61. Segerer SE, Muller N, Brandt J, Kapp M, Dietl J, Reichardt HM et al. The glycoproteinhormones activin A and inhibin A interfere with dendritic cell maturation. Reprod Biol Endocrinol 2008; 6: 17.
62. Dumitriu IE, Dunbar DR, Howie SE, Sethi T, Gregory CD. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4CD25+Foxp3 regulatory T cells. J Immunol 2009; 182: 2795-2807.
63. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999; 162: 4567-4575. (Pubitemid 29314856)
64. Mou HB, Lin MF, Cen H, Yu J, Meng XJ. TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression. J Zhejiang Univ Sci 2004; 5: 1239-1244.